Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Hypoxic-ischaemic encephalopathy? 26 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hypoxic-ischaemic encephalopathy have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.0% of all adverse event reports for ARIPIPRAZOLE.

26
Reports of Hypoxic-ischaemic encephalopathy with ARIPIPRAZOLE
0.0%
of all ARIPIPRAZOLE reports
19
Deaths
17
Hospitalizations

How Dangerous Is Hypoxic-ischaemic encephalopathy From ARIPIPRAZOLE?

Of the 26 reports, 19 (73.1%) resulted in death, 17 (65.4%) required hospitalization, and 2 (7.7%) were considered life-threatening.

Is Hypoxic-ischaemic encephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Hypoxic-ischaemic encephalopathy?

MORPHINE (72) METHADONE (69) OXYCODONE (69) GABAPENTIN (65) FENTANYL (61) ACETAMINOPHEN (58) DIAZEPAM (55) ONDANSETRON (48) TRAMADOL (48) METFORMIN (45)

Which ARIPIPRAZOLE Alternatives Have Lower Hypoxic-ischaemic encephalopathy Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Hypoxic-ischaemic encephalopathy Reports All Drugs Causing Hypoxic-ischaemic encephalopathy ARIPIPRAZOLE Demographics